Price
$16.48-17.43%Social Signal Score
Analyst Ratings
6 analystsRevenue
$421.28M+30.04%Analyst Estimates
Consensus estimates, not results. Via Financial Modeling Prep.
Company Profile
- CEO
- Erin N. Kane
- Sector
- Basic Materials
- Industry
- Chemicals - Specialty
- Employees
- 1,410
- Beta
- 1.25
- Country
- US
- Piotroski score
- 2 / 9 (Weak)
- Altman Z-score
- 1.81
Financials
Revenue
$421.28M+30.0%Net Income
$3.25M-80.3%EBITDA
$10.06M-73.1%Free Cash Flow
$-10.68M-251.5%EPS (diluted)
$0.12-77.8%Shares Outstanding (diluted)
27.60M-9.5%Operating Expenses
$22.05MCash & Debt
$7.22MReturn of Capital
$4.44MRevenue by Segment (annual)
$958.54MDividend per Share
$0.16Quote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $1.52B | $49.29M | $1.83 |
| 2024 | $1.52B | $44.15M | $1.65 |
| 2023 | $1.53B | $54.62M | $2.00 |
| 2022 | $1.95B | $171.89M | $6.15 |
| 2021 | $1.68B | $139.79M | $4.97 |
| 2020 | $1.16B | $46.08M | $1.64 |
| 2019 | $1.30B | $41.35M | $1.47 |
| 2018 | $1.51B | $66.24M | $2.20 |
| 2017 | $1.48B | $146.70M | $4.81 |
| 2016 | $1.19B | $34.15M | $1.12 |
| 2015 | $1.33B | $63.78M | $2.08 |
| 2014 | $1.79B | $83.86M | $2.74 |
| 2013 | $1.77B | $118.75M | $3.81 |
Valuation
Project earnings forward and see what return today's price implies.
Seeded from ASIX's reported EPS growth of -5.9% a year over 12 years.
- EPS in 5 years
- $1.35
- Implied price
- $12.17
- Return from $16.48
- -5.9% a year
To earn 15.0% a year on these assumptions you'd need to buy at $6.05 — -63.3% below today's price.
How sensitive is that answer?
Annual return across nearby assumptions. If the result is only attractive in one corner, that is the finding.
| growth \ P/E | 5 | 7 | 9 | 11 | 13 |
|---|---|---|---|---|---|
| -15.9% | -25.2% | -20.0% | -15.9% | -12.4% | -9.5% |
| -10.9% | -20.8% | -15.3% | -10.9% | -7.2% | -4.1% |
| -5.9% | -16.3% | -10.5% | -5.9% | -2.0% | 1.3% |
| -0.9% | -11.9% | -5.7% | -0.9% | 3.2% | 6.7% |
| 4.1% | -7.4% | -1.0% | 4.1% | 8.4% | 12.1% |
This is arithmetic on assumptions you chose, not a forecast or a recommendation. It ignores dividends, buybacks, share issuance and debt, and it assumes a company still earning money in 5 years. Change any input and the answer changes a lot — that sensitivity is the honest result, not a flaw in the model.
Signal Score (90d)
46-71.25%Social Signal Score
Mentions (3)
- Newsseekingalpha.com·58d ago·Neutral
AdvanSix: Challenges Persist, My Downgrade Was Correct AdvanSix (ASIX) faces significant short-term headwinds, with a 90% net income drop and negative FCF in 2Q26, driving a >20% share price decline. ASIX's structurally advantageous single-feedstock model is outweighed by weak end-market demand, limited pricing power, and high exposure to cyclical sectors like fertilizers and nylon. I lower my price target to $16/share, reflecting prolonged macro weakness and industry overcapacity; recovery is e
View source ↗ - Newsseekingalpha.com·59d ago·Positive
AdvanSix Inc. (ASIX) Q2 2026 Earnings Call Transcript AdvanSix Inc. (ASIX) Q2 2026 Earnings Call Transcript
View source ↗ - Newsmarketbeat.com·59d ago·Neutral
AdvanSix Q2 Earnings Call Highlights AdvanSix NYSE: ASIX reported second-quarter 2026 sales of $421 million, up approximately 3% from a year earlier, as higher pricing offset lower volumes across its portfolio. Adjusted EBITDA was $32 million, down $24 million year over year, while adjusted earnings per share declined $1.05 to $0.19.
View source ↗
Earnings
Fri, Nov 6(in 4 weeks)
Consensus estimate $-0.04 per share
Typical surprise +124.3% (median, so one quarter with a near-zero estimate can't distort it)
- Fri, Aug 7$0.19 vs $0.56miss
- Fri, May 8$-0.50 vs $-0.47miss
- Fri, Feb 20$0.03 vs $-0.06beat
- Fri, Nov 7$0.08 vs $-0.06beat
- Fri, Aug 1$1.24 vs $0.40beat
- Fri, May 2$0.93 vs $0.83beat
Estimates and results for ASIX via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Insider trading
Open-market buys and sells by ASIX officers and directors.
- Bought
- $149k
- Sold
- $1.4m
1 trade
25 trades
- Kintiroglou Achilles B.sold
- Kintiroglou Achilles B.sold
- Kintiroglou Achilles B.sold
- Kintiroglou Achilles B.sold
- Kintiroglou Achilles B.sold
- Kintiroglou Achilles B.sold
- Kintiroglou Achilles B.sold
- Kintiroglou Achilles B.sold
74 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.
Congress trades
- Thomas Richard Carpersenate · DE · disclosed Dec 1, 2016 (23d later)Sell$1,001 - $15,000
- Sheldon Whitehousesenate · RI · disclosed Nov 7, 2016 (35d later)Sell$1,001 - $15,000
- Sheldon Whitehousesenate · RI · disclosed Nov 7, 2016 (35d later)Sell$1,001 - $15,000
- Sheldon Whitehousesenate · RI · disclosed Nov 7, 2016 (35d later)Sell$1,001 - $15,000
Self-reported filings, amounts as brackets. Via Senate/House disclosures.